| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $39.1M | +1.6% |
| SG&A Expense | $17.8M | +11.4% |
| Operating Income | -$56.9M | -4.5% |
| Income Tax | $0 | — |
| Net Income | -$51.0M | -12.0% |
| EPS (Basic) | -$1.58 | -9.0% |
| EPS (Diluted) | -$1.58 | -9.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.0M | -53.8% |
| Short-term Investments | $78.1M | +3.6% |
| Current Assets | $116.4M | -23.8% |
| Total Assets | $116.5M | -27.3% |
| Current Liabilities | $5.1M | +14.5% |
| Stockholders' Equity | $111.4M | -28.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.6M | -7.6% |
| Investing Cash Flow | $4.6M | +107.4% |
| Financing Cash Flow | $275K | -99.7% |